Drug Name Mix-Ups To Be Addressed In Sen. Kennedy's Patient Safety Bill

FDA would be required to adopt a program to minimize drug name confusion under patient safety legislation proposed by Sen. Kennedy (D-Mass.).

More from Archive

More from Pink Sheet